|
|
.
See Category: Neoplasms
See Header: Intraductal carcinoma in situ of breast
ICD-10 (CM) Code and Descriptor
|
D05.12 |
Intraductal carcinoma in situ of left breast
|
D0512 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.35%
|
21.07%
|
6.79%
|
3.20%
|
1.90%
|
1.15%
|
0.74%
|
0.54%
|
0.40%
|
0.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D05.12*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
22,207
|
22,328
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
12,191
|
12,264
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
8,822
|
15,913
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
7,321
|
7,341
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
7,086
|
7,089
|
|
J3010
|
FENTANYL CITRATE INJECTION |
6,981
|
11,953
|
|
80053
|
COMPREHEN METABOLIC PANEL |
6,708
|
6,708
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
6,467
|
209,872
|
|
J2405
|
ONDANSETRON HCL INJECTION |
6,355
|
28,073
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
6,062
|
10,255
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
5,779
|
23,016
|
|
19301
|
PARTIAL MASTECTOMY |
5,304
|
5,304
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
5,264
|
7,124
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
5,195
|
5,239
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
5,069
|
5,069
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
4,726
|
31,976
|
|
77065
|
DX MAMMO INCL CAD UNI |
4,264
|
4,273
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
4,190
|
8,620
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
4,060
|
4,305
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
3,902
|
4,640
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D05.12 related to the following DRG Codes:
582-583
597-599
|
